Related Image: Chicago neuroscientist contributes to book on brains and baseball |
(Date:12/4/2008)...ire/ -- Omron Healthcare, Inc. reminds,consumers ...ft in Flex-,Spending Accounts (FSA,s) before they... their personal and family health such as home blo...oto: http://www.newscom.com/cgi-bin/prnh/2008120...m.com/cgi-bin/prnh/20081204/AQTH541-b ) , A...
(Date:12/4/2008)...ority Agree the Shortage Must Be Addressed , ,...President-elect Barack Obama and the incoming 111t...ntially complicating the process of achieving effe...Surgeons (ACS) has released a comprehensive policy..., the ACS calls on policymakers to support a refor...
(Date:12/4/2008)...FirstCall/ -- Aflac Incorporated,(NYSE: AFL ) a... the Goldman,Sachs U.S. Financial Services Confer... Kriss Cloninger III will represent Aflac Incorpor...on December 11, 2008, at 3:45 p.m. EST.,During th...ill discuss the,company,s outlook for the remaind...
(Date:12/4/2008)...d with combination of assessments, researchers say...- A combination of blood tests and other specializ...ng the cause of a common nerve problem called neur...American Academy of Neurology. , Neuropathy, w...ation and one in 12 people older than 55, usually ...
Breaking Medicine News(10 mins):Health News:Maximize Flex Spending Account Funds Before They Expire 2Health News:Maximize Flex Spending Account Funds Before They Expire 3Health News:American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage 2Health News:American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage 3Health News:American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage 4Health News:Aflac Incorporated To Present at the Goldman Sachs U.S. Financial Services Conference 2008 2Health News:Doctors Issue New Neuropathy Test Guidelines 2... with Down's Syndrome was denied an account at a b...she was 'mentally incompetent'. Charlotte and her...reatment meted out to them from the Barclays bank ...er the staff declared that the bank policies made ...
...r. Honglei Chen, of the National Institutes of Hea...may result in Parkinson’s disease//. The study was.... It said that those who work in the rotating nigh... the disease. This is because the author says tha...
...un offering "bloodless surgery" to almost 90% of i...al now joins an ever-growing number of hospitals t...icine around the country. This option was once on...ut is now provided in certain hospitals to more pa...
...rin when taken along with gentamycin can prevent t... The results of the study are especially importan...osides family of antibiotics, which includes genta...their low cost and ready availability. The study ...
Other Medicine News:Health News:Aspirin to Prevent Deafness caused by Antibiotics 2(Date:12/2/2008)...NEXA, Kan., Dec. 2 IBT Laboratorie...research laboratory specializing in immunology and...o tests to evaluate the response of patients who...ary immunodeficiency disorder, chemotherapy drugs,...gs to prevent rejection of a transplant. The compa...
(Date:12/2/2008)...OKIE, Ill., Dec. 2 Horizon Therape...ompany, today announced that two pivotal,Phase 3 ... candidate, HZT-501,met all primary endpoints. H...on product containing ibuprofen and famotidine, de...in the incidence of non-steroidal,anti-inflammato...
(Date:12/1/2008)...ICAGO, Dec. 2 New resea...eight-slice computed tomography (CT) scanner in an...ber of stroke victims who receive a potentially li...ed at North Shore Medical Center (NSMC)-Salem Hosp...he annual meeting of the Radiological Society of N...
(Date:12/1/2008)...CKVILLE, Md., Dec. 1 Van...publication in The Lancet , one of the world,s le... of its novel circadian regulator, experimental co...Rajaratnam et al(1) is entitled "Melatonin agonist...r sleep-time shift: two randomised controlled mult...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Resilience in an aging society 3A GSA showcases cutting edge meeting topics 5684 1Resilience in an aging society 3A GSA showcases cutting edge meeting topics 5684 2Resilience in an aging society 3A GSA showcases cutting edge meeting topics 5684 3Resilience in an aging society 3A GSA showcases cutting edge meeting topics 5684 4Aflac Duck Gives Back 28425 1Aflac Duck Gives Back 28425 2Aflac Duck Gives Back 28425 3Mutant Mouse Gene Offers Clues to Hearing Loss 28422 1Mutant Mouse Gene Offers Clues to Hearing Loss 28422 2How did glycine significantly decrease liver injury 3F 28418 1...WIRE)--May 7, 2007 - REGENERX,BIOPHARMACEUTICALS, ...will be speaking at the 2007 Association for Resea...Ft. Lauderdale, Florida,on May 9th to discuss TB4,...on. Neutrophil infiltration is a process closely,a...controlled, can,cause substantial tissue and organ...
... WIRE)--May 7, 2007 - OXiGENE, Inc.,(NASDAQ: OXGN,...ny,developing novel therapeutics to treat cancer a...of its Phase II combretastatin A4,phosphate (CA4P)...D) was presented at the 47th Annual Meeting of the...gy (ARVO) in Fort Lauderdale,FL. The abstract may...
Other Medicine Technology:Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 2Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 3OXiGENE Announces a Poster Presentation Highlighting Results from,its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study,MMD-213) at the 47th Annual Meeting of the Association of Research,in Vision and Ophthalmology 2OXiGENE Announces a Poster Presentation Highlighting Results from,its Study of ZYBRETSTAT CA4P in Myopic Macular Degeneration (Study,MMD-213) at the 47th Annual Meeting of the Association of Research,in Vision and Ophthalmology 3Aaron manufactures two groups of flexible lighting products. The first is available both sterile and non-sterile in three different sizes 5", 10", and 15" (refers to the flexible shaft portion of the
...maintains power to the instrument without generati...s of 50 Hz separated by .75 s; repeats every 10 s ...tanus: 50 Hz (50 pulses/s) or 100 Hz (100 pulses/s...s , Output Current: Adjustable from 0-70 mA (HI ra...
Anesthesia Associates Model 100 Compact Peripheral Nerve Stimulator, incorporates the latest state-of-the-art electronics with solid state cicuitry to ensure trouble-free operation and extended batte
Based on the original MS-III design the new MS-IV includes electrosurgery certification, enhanced keypad and battery compartment designs., ,The MiniStim® MS-IV peripheral nerve stimulator can
Medicine Products: